Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex.
Researchers observed that autoinduction of TGF-beta 1 is mediated by the AP-1 complex, highlighting the role of c-jun and c-fos in its transcriptional regulation.
Transforming Growth Factor Beta 1 · TGF-β1
Transforming growth factor-beta 1 (TGF-β1) is a multifunctional cytokine produced primarily by platelets, macrophages, and various cell types within the body, playing a crucial role in cellular growth, differentiation, and immune regulation. Researchers primarily study TGF-β1 for its involvement in various pathological processes, including fibrosis, inflammation, and tissue remodeling in conditions such as hypertension and airway diseases. Key findings indicate that TGF-β1 contributes to cardiac fibrosis by influencing myofibroblast behavior and has been implicated in the remodeling of airway tissues in response to inflammatory stimuli. Additionally, studies suggest that TGF-β1 expression is altered in conditions like adenomyosis and hypertension, highlighting its potential role in disease progression. Current research continues to explore the regulatory pathways of TGF-β1, aiming to uncover therapeutic targets for managing diseases associated with its dysregulation.
Transforming Growth Factor Beta 1 (TGF-β1) is an endogenous cytokine belonging to the growth factor category, primarily produced by various cell types including platelets, macrophages, and fibroblasts. It is part of the TGF-beta superfamily, which is known for its regulatory roles in cellular processes. TGF-β1 is synthesized as a latent precursor that requires activation to exert its biological effects. Researchers have found that TGF-β1 plays a crucial role in regulating cell growth, differentiation, and immune responses. It is extensively studied in the context of inflammatory airway diseases, cardiac fibrosis, and vascular hypertrophy. In inflammatory airway diseases, TGF-β1 is involved in tissue remodeling and immunosuppression, while in cardiac fibrosis, it affects myofibroblast activity and arrhythmogenicity. In vascular hypertrophy, TGF-β1 modulates smooth muscle cell proliferation and extracellular matrix production. The mechanism of action of TGF-β1 involves binding to TGF-beta receptors, leading to the activation of SMAD proteins and other signaling pathways that regulate gene expression. This cascade influences various cellular functions, including proliferation and differentiation. Pharmacokinetic properties of TGF-β1 are not well-defined, with limited data on its half-life and metabolism. Clinically, TGF-β1 is not directly used as a therapeutic agent but is a target for research in developing treatments for conditions like fibrosis and inflammatory diseases. Its regulatory status varies by region, with no specific approvals for clinical use as a standalone treatment.
TGF-β1 acts primarily through the TGF-beta receptor complex, which activates SMAD-dependent and SMAD-independent pathways. This activation leads to the regulation of gene expression that controls cell proliferation, differentiation, and immune responses.
TGF-β1 primarily signals through the TGF-β receptor type I (TGFBR1) and type II (TGFBR2), activating the Smad signaling pathway, particularly Smad2 and Smad3, which translocate to the nucleus to regulate gene expression. This cytokine is involved in various biological processes, including cell proliferation, differentiation, and extracellular matrix production, contributing to fibrosis and vascular hypertrophy, although the complete mechanistic understanding of its diverse effects remains elusive. Additionally, TGF-β1 can influence other pathways, such as the MAPK and PI3K/Akt pathways, further modulating cellular responses in various tissues.
Pharmacokinetic data for TGF-β1 is limited, with no specific information on half-life across different administration routes.
Temperature
Refrigerate at 2-8C
Light
Protect from light
Form
Aqueous solution: use within specified time after preparation
Notes
Ensure proper storage to maintain stability and efficacy.
TGF-β1 is generally soluble in aqueous solutions, which is relevant for its formulation in research settings.
🇩🇪DE
Data limited
🇺🇸US
Data limited
🇦🇺AU
Data limited
🇬🇧UK
Data limited
Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.
Current evidence is limited regarding the specific mechanisms by which TGF-β1 influences the electrophysiological properties of cardiac myofibroblasts and their crosstalk with cardiomyocytes, particularly in the context of arrhythmogenesis. Further research is needed to explore the long-term effects of TGF-β1 modulation in diverse populations, including those with varying degrees of cardiac fibrosis and hypertension. Additionally, the contradictory findings related to TGF-β1 expression in conditions like adenomyosis necessitate larger, well-designed randomized controlled trials to clarify its role and potential therapeutic implications in these diseases.
3,904
Total Citations
25
Human/RCT
3.6
Avg. Influence
2024
Latest
Researchers observed that autoinduction of TGF-beta 1 is mediated by the AP-1 complex, highlighting the role of c-jun and c-fos in its transcriptional regulation.
The study demonstrated that maternal sources of TGF-beta 1 contribute to the survival and normal development of TGF-beta 1 null newborn mice, indicating its critical role during development.
Researchers observed that TGF-beta 1 administration protects against collagen-induced arthritis and delays relapses in experimental allergic encephalomyelitis in mice, indicating its anti-inflammatory properties.
The study demonstrated that eosinophils are the primary source of elevated TGF-β1 mRNA in severe asthmatics, suggesting their role in airway inflammation and structural changes.
Researchers observed that TGF-β3 expression is increased in diabetic foot ulcers compared to normal skin, while TGF-β1 expression remains unchanged, potentially contributing to impaired healing.
The study demonstrated that TGF-beta 1 induces significant neutrophil recruitment to synovial tissues in rats, suggesting its involvement in synovial inflammation and hyperplasia.
Bowen Timothy, et al. · The Journal of pathology · 2013
Researchers observed that microRNAs play a significant role in regulating TGF-β1 expression, influencing tissue fibrosis and various physiological processes.
Key findings
The study demonstrated that serum TGF-beta1 levels are influenced by platelet count and that plasma is a more reliable medium for measuring TGF-beta1 than serum.
The study demonstrated that cyclosporine stimulates TGF-β1 transcription, suggesting a mechanism for its immunosuppressive and fibrogenic effects.
The study demonstrated that transforming growth factor beta 1 inhibited proliferation and induced morphological changes in cultured astrocytes while promoting extracellular matrix production.
Log cycles, set reminders and visualize serum levels.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer